In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained ...

SAN DIEGO -- The risk of progression from smoldering multiple myeloma to symptomatic disease decreased by 50% in patients treated with the anti-CD38 monoclonal antibody daratumumab (Darzalex), ...

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms ...

A sequoia tree in Sequoia National Park is still smoldering and smoking months after wildfires burned the area because the park is so dry with little rain. National Park Service A single giant sequoia ...

The FDA on Thursday approved daratumumab-hyaluronidase (Darzalex Faspro) as the first drug for high-risk smoldering multiple myeloma. Approval of the subcutaneous daratumumab product was based on ...

On a long, recent trudge through forest burned in California's 2020 Castle Fire, a six-person survey crew peered at a curiosity in the distance. "We saw a little tiny smudge of white and wondered if ...

What is Refinery Oil Sludge, Why is it Toxic, and How is it Disposed Of? Vast amounts of refinery oil sludge are produced from the process of crude oil refining. Refinery oil sludge contains toxic ...